Owner Insight Biopharmaceuticals Ltd. Hadasit Medical Research Services and Development Ltd.

Inventors Pecker, Iris; Mimon, Madelene; Moskowitz, Haim; Ben-Artzi, Hanna; Peleg, Yoav; Yacoby-Zeevi, Oron; Gilboa, Ayelet; Vlodavsky, Israel; Miron, Daphna; Feinstein, Elena; Shlomi, Yinon; Ayal-Hershkovitz, Maty

Agent Cullen & Co

Pub. Number AU-B-2004201431

Parent 768820

Filing date 6 April 2004

Wipo publication date 13 May 2004

Acceptance publication date 21 December 2006

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/24 (2006.01) Enzymes, e.g. ligases (6.) - acting on glycosyl compounds (3.2)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/56 (2006.01) Mutation or genetic engineering - acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors